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Abstract
Introduction: Breast lymphoma, either as a manifestation of primary extranodal disease or as
secondary involvement, is a rare malignancy, and its diagnosis, prognosis, and treatment have not
been clearly defined. On the other hand, Vacuum-assisted breast biopsy (VABB) is a minimally
invasive technique with ever-growing use for the diagnosis of mammographically detected, non-
palpable breast lesions.
Case presentation: A symptom-free, 56-year-old woman presented with a non-palpable BI-
RADS 4B lesion without microcalcifications. She had a positive family history for breast cancer and
a history of atypical ductal hyperplasia in the ipsilateral breast four years ago. She reported having
been treated for non-Hodgkin lymphoma 12 years ago. With the suspicion of breast cancer,
mammographically guided VABB with 11-gauge probe (on the stereotactic Fisher's table) was
performed. VABB made the diagnosis of a non-Hodgkin, grade II, B-cell germinal-center lymphoma.
VABB yielded enough tissue for immunohistochemistry/WHO classification.
Conclusion: This is the first case in the literature demonstrating the successful diagnosis of breast
lymphoma by VABB, irrespectively of the level of clinical suspicion. It should be stressed that VABB
was able to yield enough tissue for WHO classification. In general, lymphoma should never be
omitted in the differential diagnosis, since no pathognomonic radiologic findings exist for its
diagnosis.
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Introduction
Breast lymphoma, either as a manifestation of primary
extranodal disease [1,2] or as secondary involvement
[3,4], is a rare malignancy and its diagnosis, prognosis,
and treatment have not been clearly defined. Relatively
small groups of patients are reported in the literature. The
reported incidence of primary breast lymphoma ranges
from 0.04% to 0.5% of all breast malignancies [1,2]. Sec-
ondary breast lymphoma is less well studied than primary
lymphoma in the literature and it is also rare, with a
reported incidence of 0.07% [3,4]. The diagnosis of breast
lymphoma is usually performed by fine needle aspiration
cytology, with a reported sensitivity ranging from 83% to
100% [3,5].
Vacuum-assisted breast biopsy (VABB) is a minimally
invasive technique with ever-growing use for the diagno-
sis of mammographically detected, non-palpable breast
lesions. The sensitivity, specificity and fast performance of
the method have contributed to its gradual establishment
in the biopsy of suspicious breast lesions [6]. In this study,
VABB (11 G) was mammographically guided and con-
ducted on the stereotactic Fisher's table.
VABB is effective in the assessment of breast lesions both
with and without microcalcifications [6]. Exhibiting a very
low rate of false negative results and capable of excising a
great amount of tissue, VABB has been proven to have
superior sensitivity than fine needle aspiration and core
biopsy in breast cancer diagnosis [7,8].
We present the first case in the literature of a secondary
breast lymphoma diagnosed by VABB, despite the absence
of strong clinical suspicion.
Case presentation
A 56-year-old woman came to our Breast Unit for her
annual follow-up. A newly developed, non-palpable solid
lesion of diameter equal to 0.8 cm was present in the
upper outer quadrant of the left breast. The lesion did not
contain microcalcifications, and axillary lymph nodes of
small size were detected on the mammogram. The ultra-
sound examination was negative.
From the personal history, 12 years ago, a low-grade, stage
I, Non-Hodgkin lymphoma confined to the lymph nodes
of the neck was diagnosed and treated with radiation ther-
apy. The patient was symptom-free, and able to function
normally in her everyday life.
The woman had risk factors for breast cancer: positive
family history for breast cancer (mother with postmeno-
pausal breast carcinoma), a history of atypical ductal
hyperplasia (ADH) 4 years ago, diagnosed by excisional
biopsy under local anesthesia for a palpable lesion. Her
BMI was equal to 25, and she was a housewife. The age at
menarche was 15 years old and the age at drug-induced
menopause was 44 years. The patient has had two
induced abortions and three full-term pregnancies. The
duration of lactation for all three full-term pregnancies
was 15 months. There was no family history for ovarian
and prostate cancer. There was no history of intake of
estrogen.
The radiologist of our Unit characterized the suspicious
lesion as BI-RADS 4B (lesion with an intermediate suspi-
cion of malignancy) and a VABB was scheduled. Lym-
phoma was not suspected at presentation. VABB was
performed on a digital prone table (Mammotest, Fischer
Imaging, Denver, CO, USA) using 11-gauge Mammotome
vacuum probes, under local anesthesia (Figures 1, 2).
Using one main target-offset and one offset inside the
solid lesion, 24 cores were excised from the suspicious
lesion (Figures 1, 2, 3). The length of the cores varied
between 0.5 and 2.8 cm. A clip marker was placed after
biopsy and a mammogram to the affected breast con-
firmed the excision of cores in the lesion.
According to the pathological examination, the lesion was
a non-Hodgkin, grade II, germinal-center lymphoma of B-
cell origin and exhibited a nodular pattern (> 75%) (Fig-
ure 4). More specifically, the nodules were formed by cells
with morphology of centroblasts and centrocytes; the
number of centroblasts did not exceed 15 per optical field
The suspicious lesion on the screen (Fischer workstation,  VABB device) Figure 1
The suspicious lesion on the screen (Fischer workstation, 
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(×40). The stroma exhibited hyalinization where the
malignant lymphoid tissue was present. The malignant
lymphoid cells were occasionally present within the fatty
breast tissue, and a few entrapped mammary ducts were
recognized within the sclerotic stroma. Immunohisto-
chemically, the lymphoid cells were positive for CD20,
bcl-2 (Figure 5) and CD10, whereas some CD10-positive
cells were present outside the nodules. There was indica-
tion of kappa chain clonality. The Ki-67 proliferation
marker was positive in 10% of cells.
Subsequently, after second contact with the patient, and
the establishment of the diagnosis, the patient disclosed
that she had stopped her hematological follow-up 6 years
ago. She was then referred to the hematologists for further
evaluation and treatment.
Immunoreaction of the lymphoid cells to bcl-2 protein (×  200) Figure 5
Immunoreaction of the lymphoid cells to bcl-2 protein (× 
200).
The lesion after sampling Figure 3
The lesion after sampling.
The lesion at the onset of sampling Figure 2
The lesion at the onset of sampling.
Invasion of the breast parenchyma by the nodular non-Hodg- kin B-cell lymphoma (H+E × 100) Figure 4
Invasion of the breast parenchyma by the nodular non-Hodg-
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Discussion
The present case of breast NHL presented as a lesion with-
out microcalcifications. Indeed, breast NHL most com-
monly presents as a solitary, uncalcified mass. However, it
has been demonstrated that no pathognomonic radio-
logic findings exist for the differential diagnosis between
breast lymphoma and carcinoma [9]. More interestingly,
in the context of non-palpable mammographic lesions,
such as the present one, there is scarcity of data on issues
regarding the differential diagnosis.
Although the distinction between lymphoma and carci-
noma seems demanding, accurate differential diagnosis
before treatment is necessary, irrespective of the level of
suspicion. That is because the treatment of lymphoma dif-
fers radically from that of carcinoma [3]. In the hypothet-
ical scenario that a lymphoma is missed at presentation,
lumpectomy or mastectomy (unnecessary treatments for
lymphoma) might be performed.
In the present case, the existence of two significant risk fac-
tors (a diagnosis of ADH in the past and positive family
history) reinforced the clinical suspicion for breast cancer,
which is otherwise the prevailing one in the everyday con-
text of a Breast Unit. More specifically, the above two risk
factors have been associated with a relative risk equal to
9.7 in the literature [10].
Fine-needle aspiration (FNA) is the established diagnostic
procedure for the diagnosis of breast lymphomas [5,11].
FNA, however, bears certain limitations: in terms of breast
lesions in general, FNA has been proven to yield insuffi-
cient diagnostic material [12]. More specifically and
regarding breast lymphoma, FNA occasionally fails to
establish the WHO classification in secondary lesions
and, more frequently, in primary lesions [11]; this is of
particular importance, since the WHO classification is cru-
cial for the long-term management and prognosis. Given
the above inherent difficulties, the role of confirmatory
core biopsy has been discussed [3].
In the present case, VABB successfully made the diagnosis
and provided adequate tissue for the evaluation of the
molecular markers/WHO classification. Many reasons
account for this: the excision of a significant percentage of
the non-palpable solid lesion, the accurate targeting in the
stereotactic-digital setting, the multiple cores via a single
needle insertion and the large amount of tissue obtained.
Indeed, it is standard practice in our Center to obtain
more than 24 cores in each lesion, irrespectively of the
degree of clinical suspicion; this is above the majority of
existing studies (cf. [13]).
Interestingly enough, breast lymphoma has been shown
to escape diagnosis by nonimage-guided core needle
biopsy (14 G), as shown by a recent series [14]. However,
when ultrasound-guided, core biopsy has been once able
to detect breast lymphoma [15]. Our described case may
seem thus rational in the continuum of recently devel-
oped breast techniques; bearing the features explained
above, the most recently evolved technique of VABB
might be advantageous with respect to breast lymphoma.
It is tempting to speculate that the obtention of a relatively
great volume by VABB might have comparable perform-
ance to that of excisional biopsy vis-à-vis  breast lym-
phoma.
Conclusion
This is the first reported case of breast lymphoma diag-
nosed by VABB in the international literature. Despite the
lack of clinical suspicion, the lymphoma did not escape
VABB, and VABB yielded adequate tissue for WHO classi-
fication. As the experience with VABB accumulates world-
wide, the performance of the method remains to be
accurately assessed in the future.
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